Qingfeng Chen

4.9k total citations · 1 hit paper
72 papers, 2.1k citations indexed

About

Qingfeng Chen is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Qingfeng Chen has authored 72 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Immunology, 19 papers in Oncology and 15 papers in Molecular Biology. Recurrent topics in Qingfeng Chen's work include Immune Cell Function and Interaction (21 papers), CAR-T cell therapy research (10 papers) and Immunotherapy and Immune Responses (6 papers). Qingfeng Chen is often cited by papers focused on Immune Cell Function and Interaction (21 papers), CAR-T cell therapy research (10 papers) and Immunotherapy and Immune Responses (6 papers). Qingfeng Chen collaborates with scholars based in Singapore, China and United States. Qingfeng Chen's co-authors include Jianzhu Chen, Maroun Khoury, Jerry Kok Yen Chan, Zhisheng Her, Eng Eong Ooi, Fritz Lai, Joe Yeong, Han Chong Toh, Achim Weber and Marta Garnelo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Nature Communications.

In The Last Decade

Qingfeng Chen

67 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nitric Oxide-Producing Multiple Functional Nanoparticle Remodeling Tumor Microenvironment for Synergistic Photodynamic Immunotherapy against Hypoxic Tumor

2025 20 citations Shuyu Xu, Xinxin Xie et al. ACS Nano profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Qingfeng Chen Singapore	25	816	623	574	288	237	72	2.1k
Jifeng Yu China	19	694 0.9×	508 0.8×	545 0.9×	235 0.8×	113 0.5×	77	1.8k
Reem Al‐Daccak France	29	1.2k 1.5×	829 1.3×	536 0.9×	122 0.4×	201 0.8×	76	2.8k
Olivier Demaria France	12	1.6k 1.9×	644 1.0×	600 1.0×	194 0.7×	134 0.6×	18	2.1k
Lianjun Shen China	17	1.6k 1.9×	1.4k 2.3×	750 1.3×	208 0.7×	264 1.1×	49	2.8k
Chen Zhao China	23	1.2k 1.4×	1.2k 1.9×	576 1.0×	206 0.7×	534 2.3×	64	2.7k
Marco Bestagno Italy	25	462 0.6×	800 1.3×	552 1.0×	121 0.4×	197 0.8×	51	1.9k
Hilmar Berger Germany	25	372 0.5×	1.1k 1.8×	797 1.4×	262 0.9×	275 1.2×	50	2.7k
Elisabeth Naschberger Germany	32	1.5k 1.8×	1.3k 2.1×	825 1.4×	113 0.4×	361 1.5×	90	3.2k
Eisaku Kondo Japan	26	530 0.6×	1.5k 2.4×	507 0.9×	134 0.5×	264 1.1×	67	2.6k
Emmanuel C. Patin United Kingdom	16	664 0.8×	403 0.6×	553 1.0×	130 0.5×	206 0.9×	22	1.4k

Countries citing papers authored by Qingfeng Chen

Since Specialization

Citations

This map shows the geographic impact of Qingfeng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingfeng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingfeng Chen more than expected).

Fields of papers citing papers by Qingfeng Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingfeng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingfeng Chen. The network helps show where Qingfeng Chen may publish in the future.

Co-authorship network of co-authors of Qingfeng Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Qingfeng Chen. A scholar is included among the top collaborators of Qingfeng Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingfeng Chen. Qingfeng Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Jianfeng, Ruiqi Wu, Shi Hao Tan, et al.. (2025). Ultrasound triggered spatial-temporal NO gas release to enhance sonodynamic therapy and immune checkpoint blockade therapy against pancreatic cancer. Chemical Engineering Journal. 522. 167365–167365.

Xu, Shuyu, Xinxin Xie, Ping He, et al.. (2025). Nitric Oxide-Producing Multiple Functional Nanoparticle Remodeling Tumor Microenvironment for Synergistic Photodynamic Immunotherapy against Hypoxic Tumor. ACS Nano. 19(6). 6371–6387. 20 indexed citations breakdown →

Yeo, Siok Ping, Lindsay Kua, Chek Meng Poh, et al.. (2024). B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors. Cancer Research Communications. 4(6). 1410–1429. 3 indexed citations

Yang, Yufan, Xuefei Liu, Junhao Chen, et al.. (2024). Circulating tumour cell clusters: isolation, biological significance and therapeutic implications. SHILAP Revista de lepidopterología. 3(1). e000437–e000437. 6 indexed citations

Yau, Hong‐Tzong, et al.. (2024). From computed tomography to 3D printed heterogeneous scaffolds: A novel approach to simulating bone characteristics using octree adaptive subdivision. Materials & Design. 245. 113277–113277.

Carter, Jean-Michel, Jianbiao Zhou, Qingfeng Chen, et al.. (2024). Aberrant non-canonical NF-κB signalling reprograms the epigenome landscape to drive oncogenic transcriptomes in multiple myeloma. Nature Communications. 15(1). 2513–2513. 6 indexed citations

Zhu, Ying, Kylie Su Mei Yong, Huanle Gong, et al.. (2024). IL-37 dampens immunosuppressive functions of MDSCs via metabolic reprogramming in the tumor microenvironment. Cell Reports. 43(3). 113835–113835. 16 indexed citations

Bae, Ki Hyun, et al.. (2024). Potentiating Gilteritinib Efficacy Using Nanocomplexation with a Hyaluronic Acid–Epigallocatechin Gallate Conjugate. Polymers. 16(2). 225–225.

Wu, Xiaolin, Francesca Lim, Yie Hou Lee, et al.. (2024). A high-density microfluidic bioreactor for the automated manufacturing of CAR T cells. Nature Biomedical Engineering. 8(12). 1571–1591. 22 indexed citations

10.

Ng, Chee H., Cheah C. Seh, Richard Ong, et al.. (2024). Novel OX40 and 4-1BB derived spacers enhance CD30 CAR activity and safety in CD30 positive lymphoma models. Molecular Therapy. 32(10). 3504–3521. 3 indexed citations

11.

Chen, Qingfeng, et al.. (2023). Hepatocellular carcinoma subtypes based on metabolic pathways reveals potential therapeutic targets. Frontiers in Oncology. 13. 1086604–1086604. 6 indexed citations

12.

Lam, Maxine, Jose Antonio Reales‐Calderón, Jin Rong Ow, et al.. (2023). G9a/GLP inhibition during ex vivo lymphocyte expansion increases in vivo cytotoxicity of engineered T cells against hepatocellular carcinoma. Nature Communications. 14(1). 563–563. 14 indexed citations

13.

Song, Yuan, Kylie Su Mei Yong, Ying Zhu, et al.. (2023). IL12/18/21 Preactivation Enhances the Antitumor Efficacy of Expanded γδT Cells and Overcomes Resistance to Anti–PD-L1 Treatment. Cancer Immunology Research. 11(7). 978–999. 9 indexed citations

14.

Her, Zhisheng, Li Ching Ong, Yuehua Wang, et al.. (2023). Expansion of human bone marrow-derived mesenchymal stromal cells with enhanced immunomodulatory properties. Stem Cell Research & Therapy. 14(1). 259–259. 13 indexed citations

15.

Bae, Ki Hyun, et al.. (2022). Self-Assembled Daunorubicin/Epigallocatechin Gallate Nanocomplex for Synergistic Reversal of Chemoresistance in Leukemia. International Journal of Molecular Sciences. 24(1). 381–381. 7 indexed citations

16.

Zhao, Heng, Weijian Ye, Jianxiong Guo, et al.. (2022). Development of RAG2-/-IL2Rγ-/Y immune deficient FAH-knockout miniature pig. Frontiers in Immunology. 13. 950194–950194. 7 indexed citations

17.

Ceccarello, Erica, Tommaso Tabaglio, Sarene Koh, et al.. (2021). Splice-Switching Antisense Oligonucleotides as a Targeted Intrinsic Engineering Tool for Generating Armored Redirected T Cells. Nucleic Acid Therapeutics. 31(2). 145–154. 5 indexed citations

18.

Hong, Xin, Thanh Nguyen, Qingfeng Chen, et al.. (2014). Opposing activities of the R as and H ippo pathways converge on regulation of YAP protein turnover. The EMBO Journal. 33(21). 2447–2457. 94 indexed citations

19.

Chen, Qingfeng. (2006). Clinical Research on "Baihe Wendan Decoction" in Treating Insomnia of Internal Disturbance of Phlegm Heat. Shanghai Journal of Traditional Chinese Medicine. 1 indexed citations

20.

Chen, Qingfeng, et al.. (2006). Quality of life and medical care needs of people living with HIV/AIDS in Chongqing. Chinese Journal of AIDS & STD. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact